127 related articles for article (PubMed ID: 1925514)
1. Port-A-Cath: a study of complication rates.
Robinson MO; Halverson P
S D J Med; 1991 Jul; 44(7):187-90. PubMed ID: 1925514
[TBL] [Abstract][Full Text] [Related]
2. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
Subramaniam A; Kim KH; Bryant SA; Kimball KJ; Huh WK; Straughn JM; Estes JM; Alvarez RD
Gynecol Oncol; 2011 Oct; 123(1):54-7. PubMed ID: 21742372
[TBL] [Abstract][Full Text] [Related]
3. Long-term central venous catheters: issues for care.
Wickham R; Purl S; Welker D
Semin Oncol Nurs; 1992 May; 8(2):133-47. PubMed ID: 1621004
[TBL] [Abstract][Full Text] [Related]
4. The mechanisms of failure of totally implantable central venous access system: analysis of 73 cases with fracture of catheter.
Lin CH; Wu HS; Chan DC; Hsieh CB; Huang MH; Yu JC
Eur J Surg Oncol; 2010 Jan; 36(1):100-3. PubMed ID: 19709847
[TBL] [Abstract][Full Text] [Related]
5. Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy.
Poorter RL; Lauw FN; Bemelman WA; Bakker PJ; Taat CW; Veenhof CH
Eur J Cancer; 1996 Dec; 32A(13):2262-6. PubMed ID: 9038608
[TBL] [Abstract][Full Text] [Related]
6. Venous access ports: frequency and management of complications in oncology patients.
Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH
Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390
[TBL] [Abstract][Full Text] [Related]
7. Future dimensions in vascular access--peripheral implantable ports.
McKee J
J Intraven Nurs; 1991; 14(6):387-93. PubMed ID: 1748920
[TBL] [Abstract][Full Text] [Related]
8. Surgically implanted subcutaneous venous access devices in cancer patients.
Repelaer van Driel OJ; Kuin CM; van de Velde CJ
Neth J Surg; 1988 Jun; 40(4):97-9. PubMed ID: 3217033
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of outcomes and survivals for two central venous access port systems.
Hou SM; Wang PC; Sung YC; Lee HH; Liu HT; Chen YH
J Surg Oncol; 2005 Jul; 91(1):61-6. PubMed ID: 15999349
[TBL] [Abstract][Full Text] [Related]
10. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life.
Bow EJ; Kilpatrick MG; Clinch JJ
J Clin Oncol; 1999 Apr; 17(4):1267. PubMed ID: 10561188
[TBL] [Abstract][Full Text] [Related]
11. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.
Ng F; Mastoroudes H; Paul E; Davies N; Tibballs J; Hochhauser D; Mayer A; Begent R; Meyer T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):551-6. PubMed ID: 17517500
[TBL] [Abstract][Full Text] [Related]
12. Outpatient implantation of a central venous access system in gynecologic oncology patients.
Shen-Gunther J; Mannel RS; Walker JL; Gold MA; Johnson GA
J Reprod Med; 2003 Nov; 48(11):875-81. PubMed ID: 14686020
[TBL] [Abstract][Full Text] [Related]
13. Prolonged venous access in cancer patients.
Guenier C; Ferreira J; Pector JC
Eur J Surg Oncol; 1989 Dec; 15(6):553-5. PubMed ID: 2599125
[TBL] [Abstract][Full Text] [Related]
14. Central venous catheter with subcutaneous injection port (Port-A-Cath): 8 years clinical follow up with children.
Wesenberg F; Flaatten H; Janssen CW
Pediatr Hematol Oncol; 1993; 10(3):233-9. PubMed ID: 8217538
[TBL] [Abstract][Full Text] [Related]
15. Advances in venous access devices and nursing management strategies.
Wickham RS
Nurs Clin North Am; 1990 Jun; 25(2):345-64. PubMed ID: 2110664
[TBL] [Abstract][Full Text] [Related]
16. Catheter outcomes in home infusion.
Leone M; Dillon LR
J Infus Nurs; 2008; 31(2):84-91. PubMed ID: 18344768
[TBL] [Abstract][Full Text] [Related]
17. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
18. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
Chang YF; Lo AC; Tsai CH; Lee PY; Sun S; Chang TH; Chen CC; Chang YS; Chen JR
Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844
[TBL] [Abstract][Full Text] [Related]
19. Safe use of power injectors with central and peripheral venous access devices for pediatric CT.
Kaste SC; Young CW
Pediatr Radiol; 1996; 26(8):499-501. PubMed ID: 8753658
[TBL] [Abstract][Full Text] [Related]
20. A new peripherally implanted subcutaneous permanent central venous access device for patients requiring chemotherapy.
Salem RR; Ward BA; Ravikumar TS
J Clin Oncol; 1993 Nov; 11(11):2181-5. PubMed ID: 8229132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
